• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: B.BRAUN MEDICAL SAS CELSITE; ACCESS PORT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

B.BRAUN MEDICAL SAS CELSITE; ACCESS PORT SYSTEM Back to Search Results
Model Number 4437027
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Death (1802); Post Operative Wound Infection (2446)
Event Date 02/17/2019
Event Type  Death  
Manufacturer Narrative
We are currently trying to obtain more information about this incident, especially the batch number of the device in order to perform a review of the manufacturing records.The review of the customer complaints database does not show any increasing trend for infection following access port implantation.The global complaint rate for infection on celsite access ports is very low: (b)(4).
 
Event Description
Infection detected 48hours after the implantation of the access port.Streptococcus a detected.Patient dead 4 days after, due to multi visceral failures.
 
Manufacturer Narrative
Note : product reference:(b)(4) is not cleared for sales in the usa, but similar product reference: (b)(4) is cleared under #: 510k130576.Batch history review: we have checked the manufacturing file of batch nr 36942215 which complies with our specifications and do not present any discrepancy.The sterilization records, the lal and bioburden test results were reviewed.All data are compliant with our requirements.No other similar complaint has been reported to us on this batch of 249 access ports released in january 2019.Investigation: we did not received the complaint sample for investigation.The information provided mentioned that the streptococcus a bacteria was at the origin of the infection.This bacteria is naturally present on the skin.We perform periodic bioburden tests on our non-sterile products (before sterilization) and identification of the viables.Streptococcus a has never been identified in our products during our routine inspections.Conclusion: the received elements do not allow us to conclude on the real cause of the infection.Our records show that these batches of celsite access ports have been manufactured, packed and sterilized in compliance with our specifications.The review of the customer complaints database does not show any increasing trend for infection following access port implantation.The global complaint rate for infection on celsite access ports is (b)(4).No corrective action is envisaged.
 
Event Description
Implantation of the access port on (b)(6) 2019.On (b)(6) 2019: fever and acute renal insufficiency.On (b)(6) 2019: multi-visceral deficiencies.Patient's death.Streptococcus a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELSITE
Type of Device
ACCESS PORT SYSTEM
Manufacturer (Section D)
B.BRAUN MEDICAL SAS
26 rue armengaud
saint cloud, 92210
FR  92210
MDR Report Key8782537
MDR Text Key150805964
Report Number9612452-2019-00081
Device Sequence Number1
Product Code LJT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Type of Report Initial,Followup
Report Date 08/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date01/02/2024
Device Model Number4437027
Device Lot Number36942215
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/19/2019
Initial Date FDA Received07/11/2019
Supplement Dates Manufacturer Received06/19/2019
Supplement Dates FDA Received08/13/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-